Gurney H - Search Results

1

Recombinant human GM-CSF in small cell lung cancer: a phase I/II study.

Anderson H, Gurney H, Thatcher N, Swindell R, Scarffe JH, Weiner J. Anderson H, et al. Among authors: gurney h. Recent Results Cancer Res. 1991;121:155-61. doi: 10.1007/978-3-642-84138-5_17. Recent Results Cancer Res. 1991. PMID: 1650015 Clinical Trial.

2

Infection risk in patients with small cell lung cancer receiving intensive chemotherapy and recombinant human granulocyte-macrophage colony-stimulating factor.

Gurney H, Anderson H, Radford J, Potter MR, Swindell R, Steward W, Kamthan A, Chang J, Weiner J, Thatcher N, et al. Gurney H, et al. Eur J Cancer. 1992;28(1):105-12. doi: 10.1016/0959-8049(92)90396-j. Eur J Cancer. 1992. PMID: 1314626 Clinical Trial.

3

Haemopoietic cell kinetics in humans treated with rGM-CSF.

Lord BI, Gurney H, Chang J, Thatcher N, Crowther D, Dexter TM. Lord BI, et al. Among authors: gurney h. Int J Cancer. 1992 Jan 2;50(1):26-31. doi: 10.1002/ijc.2910500107. Int J Cancer. 1992. PMID: 1370226

4

Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial.

Pettengell R, Gurney H, Radford JA, Deakin DP, James R, Wilkinson PM, Kane K, Bentley J, Crowther D. Pettengell R, et al. Among authors: gurney h. Blood. 1992 Sep 15;80(6):1430-6. Blood. 1992. PMID: 1381626 Free article. Clinical Trial.

5

Ifosfamide and mitomycin in combination for the treatment of patients with progressive advanced non-small cell lung cancer.

Gurney H, de Campos ES, Dodwell D, Kamthan A, Thatcher N. Gurney H, et al. Eur J Cancer. 1991;27(5):565-8. doi: 10.1016/0277-5379(91)90218-3. Eur J Cancer. 1991. PMID: 1647182

6

A phase II study of ifosfamide and a2b-interferon in advanced non-small-cell lung cancer.

Lind MJ, Gomm S, Simmonds AP, Ashcroft L, Kamthan A, Gurney H, Thatcher N. Lind MJ, et al. Among authors: gurney h. Cancer Chemother Pharmacol. 1991;28(2):142-4. doi: 10.1007/BF00689705. Cancer Chemother Pharmacol. 1991. PMID: 1647893

7

Five year follow-up and dose delivery analysis of cisplatin, iproplatin or carboplatin in combination with cyclophosphamide in advanced ovarian carcinoma.

Gurney H, Crowther D, Anderson H, Murphy D, Prendiville J, Ranson M, Mayor P, Swindell R, Buckley CH, Tindall VR. Gurney H, et al. Ann Oncol. 1990 Nov;1(6):427-33. Ann Oncol. 1990. PMID: 2083186 Free article. Clinical Trial.

8

Dose intensity in cancer chemotherapy.

Dodwell DJ, Gurney H, Thatcher N. Dodwell DJ, et al. Among authors: gurney h. Br J Cancer. 1990 Jun;61(6):789-94. doi: 10.1038/bjc.1990.178. Br J Cancer. 1990. PMID: 2164831 Free PMC article. Review. No abstract available.

9

Escalating drug delivery in cancer chemotherapy: a review of concepts and practice--Part 1.

Gurney H, Dodwell D, Thatcher N, Tattersall MH. Gurney H, et al. Ann Oncol. 1993 Jan;4(1):23-34. doi: 10.1093/oxfordjournals.annonc.a058348. Ann Oncol. 1993. PMID: 8435358 Free article. Review. No abstract available.

10

Escalating drug delivery in cancer chemotherapy: a review of concepts and practice--Part 2.

Gurney H, Dodwell D, Thatcher N, Tattersall MH. Gurney H, et al. Ann Oncol. 1993 Feb;4(2):103-15. doi: 10.1093/oxfordjournals.annonc.a058411. Ann Oncol. 1993. PMID: 8448079 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters